Glaucoma Trial, Recruiting (NCT05523622)

Glaucoma Trial, Recruiting NCT05523622 Sponsor: State University of New York at Buffalo Condition: Glaucoma

Printed from Voxsanity (voxsanity.com.au) — NCT05523622 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Glaucoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to sign and date a consent form agreeing to take part in the study
You are willing to follow all study procedures and be available for the full length of the study
You are a man or woman between 18 and 99 years old
You are in good enough general health to travel to and attend your appointment on the day of the study

Who may not be able to join:

You are under 18 years old
You are unable or unwilling to sign a consent form to take part in the study
You have a condition that makes it difficult to get an accurate eye pressure reading, such as uncontrollable eye blinking (blepharospasm), involuntary eye movement (nystagmus), significant problems with the clear front surface of the eye (corneal pathology), or you wear contact lenses and cannot remove them for the appointment
You have significant thinning of the white part of your eye (the sclera) (confirm with trial site)
You have a known allergy to proparacaine (a numbing eye drop) or fluorescein (an eye dye), as both are used during the eye pressure measurement part of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 716-408-6909

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05523622

Sponsor: State University of New York at Buffalo

Phase: Not Applicable

Status: Recruiting

Condition: Glaucoma

Trial contact: 716-408-6909

More information: https://clinicaltrials.gov/study/NCT05523622

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to sign and date a consent form agreeing to take part in the study
You are willing to follow all study procedures and be available for the full length of the study
You are a man or woman between 18 and 99 years old
You are in good enough general health to travel to and attend your appointment on the day of the study

Who may not be able to join:

You are under 18 years old
You are unable or unwilling to sign a consent form to take part in the study
You have a condition that makes it difficult to get an accurate eye pressure reading, such as uncontrollable eye blinking (blepharospasm), involuntary eye movement (nystagmus), significant problems with the clear front surface of the eye (corneal pathology), or you wear contact lenses and cannot remove them for the appointment
You have significant thinning of the white part of your eye (the sclera) (confirm with trial site)
You have a known allergy to proparacaine (a numbing eye drop) or fluorescein (an eye dye), as both are used during the eye pressure measurement part of the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

State University of New York at Buffalo

Registry

ClinicalTrials.gov

Start date

1 August 2022

Est. completion

31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Intraocular Pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov